Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Limb girdle muscular dystrophies: classification, clinical spectrum and emerging therapies

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Editorial: Remaining diagnostic issues and start of a treatment era for muscle diseases

    Research output: Contribution to journalEditorialResearchpeer-review

  2. The window of opportunity for treatment of progressive multiple sclerosis

    Research output: Contribution to journalReviewResearchpeer-review

  3. The changing course of multiple sclerosis: rising incidence, change in geographic distribution, disease course, and prognosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. The influence of lifestyle and gender on cluster headache

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Exercise in muscle disorders: what is our current state?

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Quantitative Muscle MRI and Clinical Findings in Women With Pathogenic Dystrophin Gene Variants

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Myopathy can be a key phenotype of membrin (GOSR2) deficiency

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Fatigue, physical activity and associated factors in 779 patients with myasthenia gravis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Cardiac Involvement in Women With Pathogenic Dystrophin Gene Variants

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Efficacy and Safety of Rozanolixizumab in Moderate to Severe Generalized Myasthenia Gravis: A Phase 2 Randomized Control Trial

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

PURPOSE OF REVIEW: The aim of the study was to describe the clinical spectrum of limb girdle muscular dystrophies (LGMDs), the pitfalls of the current classification system for LGMDs, and emerging therapies for these conditions.

RECENT FINDINGS: Close to half of all LGMD subtypes have been discovered within the last 6 years of the 21-year-period in which the current classification system for LGMD has existed. The number of letters for annotation of new recessive LGMD conditions is exhausted, and multiple already classified LGMDs do not strictly fulfill diagnostic criteria for LGMD or are registered in other classification systems for muscle disease. On the contrary, diseases that fulfill classical criteria for LGMD have found no place in the LGMD classification system. These shortcomings call for revision/creation of a new classification system for LGMD. The rapidly expanding gene sequencing capabilities have helped to speed up new LGMD discoveries, and unveiled pheno-/genotype relations. Parallel to this progress in identifying new LGMD subtypes, emerging therapies for LGMDs are under way, but no disease-specific treatment is yet available for nonexperimental use.

SUMMARY: The field of LGMD is rapidly developing from a diagnostic and therapeutic viewpoint, but a uniform and universally agreed classification system for LGMDs is needed.

Original languageEnglish
JournalCurrent Opinion in Neurology
Volume29
Issue number5
Pages (from-to)635-41
Number of pages7
ISSN1350-7540
DOIs
Publication statusPublished - Oct 2016

    Research areas

  • Journal Article

ID: 49287800